Our study indicated that the HG/STAT3/HIF-1α signaling pathway might involve in all those processes and the treatment using STAT3 inhibitor could partly attenuate the progression of peritoneal fibrosis, angiogenesis and inflammation. The gene discussed is HIF1A; the disease is Peritoneal Fibrosis.